Health and Healthcare
701 Articles
With earnings having just been released for some of the top biotech companies, we saw a flurry of analyst calls…
The April 15 short interest data have been compared with the previous report, and short interest decreased across the board…
The March 31 short interest data have been compared with the previous report, and short interest decreased across the board…
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol…
The February 29 short interest data have been compared with the previous report, and short interest decreased across the board…
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…
The February 12 short interest data have been compared with the previous report, and short interest increased across the board…
The January 29 short interest data have been compared with the previous report, and short interest was mixed in most…
A recent Jefferies research note indicates that the multiples for the four largest biotechs have dipped below that of the…
Amgen reported better-than-expected fourth-quarter financial results after the markets closed Thursday.
Short interest increased in most of these selected biotech stocks for the most recent settlement date.
Credit Suisse sees solid fundamentals, despite a harsh market landscape, for large-cap biotech firms. It initiated several top biotech stocks…
The short interest data are out for the December 31 settlement date. 24/7 Wall St. has reviewed the top biotech…
Which well-known and large cap stocks to do the major analysts on Wall Street like for 2016? Here are 10.
Goldman Sachs has seen many top stocks offering great rewards for 2016. The reason may be different for each, but…
Our top personal finance-related articles today. Your wallet will thank you later.